Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (USD $)	Common Stock	Additional Paid-in Capital	Deficit accumulated during development stage	Other	Total
Balance at Dec. 31, 2000	$ 0	$ 0	$ 0	$ 0	$ 0
Balance (in shares) at Dec. 31, 2000	0
Common stock issued during the period, net of expenses	203	3,797	0	(4,000)	0
Common stock issued during the period, net of expenses (in shares)	203,355
Net income (loss)	0	0	(56,796)	0	(56,796)
Balance at Dec. 31, 2001	203	3,797	(56,796)	(4,000)	(56,796)
Balance (in shares) at Dec. 31, 2001	203,355
Proceeds from subscription receivable	0	0	0	4,000	4,000
Stock issued at $0.02 per share for license rights	51	949	0	0	1,000
Stock issued at $0.02 per share for license rights (in shares)	50,839
Stock options issued for consulting services	0	60,589	0	(60,589)	0
Amortization of unearned consulting services	0	0	0	22,721	22,721
Common stock issued during the period, net of expenses	61	1,704,257	0	0	1,704,318
Common stock issued during the period, net of expenses (in shares)	60,866
Net income (loss)	0	0	(1,037,320)	0	(1,037,320)
Balance at Dec. 31, 2002	315	1,769,592	(1,094,116)	(37,868)	637,923
Balance (in shares) at Dec. 31, 2002	315,060
Stock issued in connection with acquisition	126	2,336,115	0	0	2,336,241
Stock issued in connection with acquisition (in shares)	125,752
Unrealized gain (loss) on short-term investments	0	0	0	(7,760)	(7,760)
Payment for fractional shares for stock combination	0	(300)	0	0	(300)
Preferred stock dividends (including imputed amounts)	0	418,182	(418,182)	0	0
Amortization of unearned consulting services	0	0	0	37,868	37,868
Preferred stock issued during the period, net of expenses	0	9,045,176	0	1,000	9,046,176
Common stock issued during the period, net of expenses	26	743,665	0	0	743,691
Common stock issued during the period, net of expenses (in shares)	26,436
Net income (loss)	0	0	(5,960,907)	0	(5,960,907)
Balance at Dec. 31, 2003	467	14,312,430	(7,473,205)	(6,760)	6,832,932
Balance (in shares) at Dec. 31, 2003	467,248
Unrealized gain (loss) on short-term investments	0	0	0	20,997	20,997
Preferred stock dividend accrued	0	0	(585,799)	0	(585,799)
Preferred stock dividends paid by issuance of shares	0	281,073	0	25	281,098
Conversion of preferred stock to common stock	31	140	0	(171)	0
Conversion of preferred stock to common stock (in shares)	31,005
Warrants issued for consulting services	0	125,558	0	(120,968)	4,590
Amortization of unearned consulting services	0	0	0	100,800	100,800
Exercise of stock options	1	30,099	0	0	30,100
Exercise of stock options (in shares)	552
Common stock issued during the period, net of expenses	67	3,361,651	0	0	3,361,718
Common stock issued during the period, net of expenses (in shares)	67,379
Net income (loss)	0	0	(5,896,031)	0	(5,896,031)
Balance at Dec. 31, 2004	566	18,110,951	(13,955,035)	(6,077)	4,150,405
Balance (in shares) at Dec. 31, 2004	566,184
Stock issued in connection with acquisition	215	11,052,769	0	0	11,052,984
Stock issued in connection with acquisition (in shares)	214,621
Unrealized gain (loss) on short-term investments	0	0	0	(12,250)	(12,250)
Exercise of warrants	6	68,485	0	0	68,491
Exercise of warrants (in shares)	5,597
Preferred stock dividend accrued	0	0	(175,663)	0	(175,663)
Preferred stock dividends paid by issuance of shares	0	477,736	0	42	477,778
Conversion of preferred stock to common stock	163	733	0	(896)	0
Conversion of preferred stock to common stock (in shares)	162,937
Common stock issued in satisfaction of accounts payable	13	749,987	0	0	750,000
Common stock issued in satisfaction of accounts payable (in shares)	13,513
Exercise of stock options	1	32,399	0	0	32,400
Exercise of stock options (in shares)	648
Common stock issued during the period, net of expenses	238	12,249,971	0	0	12,250,209
Common stock issued during the period, net of expenses (in shares)	238,354
Share-based compensation	0	66,971	0	20,168	87,139
Net income (loss)	0	0	(19,140,997)	0	(19,140,997)
Balance at Dec. 31, 2005	1,202	42,810,002	(33,271,695)	987	9,540,496
Balance (in shares) at Dec. 31, 2005	1,201,854
Unrealized gain (loss) on short-term investments	0	0	0	(987)	(987)
Costs associated with private placement	0	(15,257)	0	0	(15,257)
Cashless exercise of warrants	0	0	0	0	0
Cashless exercise of warrants (in shares)	547
Share-based compensation	0	1,675,499	0	0	1,675,499
Net income (loss)	0	0	(9,695,123)	0	(9,695,123)
Balance at Dec. 31, 2006	1,202	44,470,244	(42,966,818)	0	1,504,628
Balance (in shares) at Dec. 31, 2006	1,202,401
Exercise of warrants	0	7,233	0	0	7,233
Exercise of warrants (in shares)	206
Warrants issued for consulting services	0	83,670	0	0	83,670
Common stock issued in satisfaction of accounts payable	1	19,999	0	0	20,000
Common stock issued in satisfaction of accounts payable (in shares)	556
Common stock issued with in-licensing agreement at $45.00 per share	2	112,498	0	0	112,500
Common stock issued with in-licensing agreement at $45.00 per share (in shares)	2,500
Common stock issued with in-licensing agreement at $40.00per share	3	119,997	0	0	120,000
Common stock issued with in-licensing agreement at $40.00per share (in shares)	3,000
Cashless exercise of warrants	0	(6)	0	0	(6)
Cashless exercise of warrants (in shares)	112
Common stock issued during the period, net of expenses	204	7,851,981	0	0	7,852,185
Common stock issued during the period, net of expenses (in shares)	203,710
Share-based compensation	0	1,440,956	0	0	1,440,956
Net income (loss)	0	0	(12,032,252)	0	(12,032,252)
Balance at Dec. 31, 2007	1,412	54,106,572	(54,999,070)	0	(891,086)
Balance (in shares) at Dec. 31, 2007	1,412,485
Sale of warrant	0	150,000	0	0	150,000
Warrants issued with secured 12% notes	0	170,128	0	0	170,128
Share-based compensation	0	463,890	0	0	463,890
Net income (loss)	0	0	(4,268,858)	0	(4,268,858)
Balance at Dec. 31, 2008	1,412	54,890,590	(59,267,928)	0	(4,375,926)
Balance (in shares) at Dec. 31, 2008	1,412,485
Cumulative effect of a change in accounting principle	0	(150,000)	127,778	0	(22,222)
Balance at January 1, 2009, as adjusted	1,412	54,740,590	(59,140,150)	0	(4,398,148)
Balance at January 1, 2009, as adjusted (in shares)	1,412,485
Warrants issued with secured 12% notes	0	46,125	0	0	46,125
Warrant issued to placement agent - secured 12% notes	0	6,919	0	0	6,919
Share-based compensation	0	353,438	0	0	353,438
Net income (loss)	0	0	(2,793,285)	0	(2,793,285)
Balance at Dec. 31, 2009	1,412	55,147,072	(61,933,435)	0	(6,784,951)
Balance (in shares) at Dec. 31, 2009	1,412,485
Common stock issued during the period, net of expenses	866	2,584,621	0	0	2,585,487
Common stock issued during the period, net of expenses (in shares)	865,572
Shares issued and issuable in Merger	141	1,475,906	0	15,890	1,491,937
Shares issued and issuable in Merger (in shares)	141,248
Derivative liability associated with issuance of common stock at $0.07	0	(3,497,898)	0	0	(3,497,898)
Share-based compensation	0	217,479	0	0	217,479
Net income (loss)	0	0	623,645	0	623,645
Balance at Dec. 31, 2010	2,419	55,927,180	(61,309,790)	15,890	(5,364,301)
Balance (in shares) at Dec. 31, 2010	2,419,305
Preferred stock dividends (including imputed amounts)					0
Shares issued and issuable in Merger	177	220,524	0	0	220,701
Shares issued and issuable in Merger (in shares)	176,561
Derivative liability associated with issuance of common stock at $0.07	0	(115,000)	0	0	(115,000)
Share-based compensation	0	13,613	0	0	13,613
Beneficial conversion feature of Secured 12% Notes Payable and interest	0	2,245,596	0	0	2,245,596
Net income (loss)	0	0	849,844	0	849,844
Balance at Jun. 30, 2011	$ 2,596	$ 58,291,913	$ (60,459,946)	$ 15,890	$ (2,149,547)
Balance (in shares) at Jun. 30, 2011	2,595,866